References
- ACOG practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–1133.
- Niroomanesh S, Shojaei K, Moghadam SF, et al. Effect of prenatal betamethasone on fetal, uteroplacental, and maternal blood flow velocity in pregnancies complicated by fetal growth restriction. Int J Gynaecol Obstet. 2015;130(3):270–273.
- Baschat AA, Gembruch U, Reiss I, et al. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol. 2000;16(5):407–413.
- Shojaei K, Mohammadi N. Comparing the effects of antenatal betamethasone on Doppler velocimetry between intrauterine growth restriction with and without preeclampsia. Glob J Health Sci. 2015;7(2):344–350.
- Berkley E, Chauhan SP, Abuhamad A. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol. 2012;206(4):300–308.
- Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320.
- Nozaki AM, Francisco RP, Fonseca ES, et al. Fetal hemodynamic changes following maternal betamethasone administration in pregnancies with fetal growth restriction and absent end-diastolic flow in the umbilical artery. Acta Obstet Gynecol Scand. 2009;88(3):350–354.
- Robertson MC, Murila F, Tong S, et al. Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus. Obstet Gynecol. 2009;113(3):636–640.
- Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999;353(9162):1404–1407.
- Piazze J, Dillon KC, Cerekja A. Betamethasone effects on umbilical arteries and ductus venosus Doppler velocity waveforms in growth-restricted fetuses. J Matern Fetal Neonatal Med. 2012;25(7):1179–1182.
- Miller SL, Supramaniam VG, Jenkin G, et al. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus. Am J Obstet Gynecol. 2009;201(6):613.e1–613.e8.
- Simchen MJ, Alkazaleh F, Adamson SL, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004;190(2):296–304.
- Thuring A, Malcus P, Marsal K. Effect of maternal betamethasone on fetal and uteroplacental blood flow velocity waveforms. Ultrasound Obstet Gynecol. 2011;37(6):668–672.
- Wijnberger LD, Bilardo CM, Hecher K, et al. Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growth-restricted fetuses. Ultrasound Obstet Gynecol. 2004;23(6):584–589.
- Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol. 1976;126(5):555–564.
- Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab. 1995;80(10):2888–2893.
- Hata T, Hashimoto M, Manabe A, et al. Maternal and fetal nitric oxide synthesis is decreased in pregnancies with small for gestational age infants. Hum Reprod. 1998;13(4):1070–1073.
- Potter SM, Dennedy MC, Morrison JJ. Corticosteroids and fetal vasculature: effects of hydrocortisone, dexamethasone and betamethasone on human umbilical artery. BJOG. 2002;109(10):1126–1131.
- Vadivelu P, Keepanasseril A, Plakkal N. Improvement of cardiac function in fetuses with growth restriction following antenatal betamethasone administration: fact or artifact? J Matern Fetal Neonatal Med. 2019;11:1–7.
- Edwards A, Baker LS, Wallace EM. Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone. Ultrasound Obstet Gynecol. 2002;20(3):240–244.
- DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015;213(1):5–15.